SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-08-035451
Filing Date
2008-06-05
Accepted
2008-06-05 17:07:16
Documents
1
Period of Report
2008-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 16298
  Complete submission text file 0001209191-08-035451.txt   18070
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Issuer) CIK: 0001047699 (see all company filings)

IRS No.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 7 ROSZEL RD 5TH FLOOR PRINCETON NJ 08540
Business Address (609)580-8012
ANDRZEJEWSKI STEPHEN J (Reporting) CIK: 0001321648 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15875 | Film No.: 08883710